Global Metabolomics Market Set for Rapid Growth, to Reach Above USD 2,500.0 Million in 2021
Sarasota, FL -- (SBWIRE) -- 11/09/2016 -- The report covers forecast and analysis for the metabolomics market on a global and regional level. According to the report, the global demand for metabolomics was valued at over USD 675.0 million in 2015 and it is expected to reach above USD 2,500.0 million in 2021, growing at a CAGR of above 25.0% between 2016 and 2021.The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the metabolomics market on a global level.
In order to give the users of this report a comprehensive view on the metabolomics market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter's five forces model for the metabolomics market has also been included. The study encompasses a market attractiveness analysis, wherein technology segments are benchmarked based on their market size, growth rate and general attractiveness.
Get a copy of free Sample Report @http://bit.ly/2cqo75n
Metabolites are substances or compounds found in the cell, they are intermediate products catalyzed by enzymes in the metabolism process. Signaling molecules, hormones, metabolic intermediates and secondary metabolites are some of the types of metabolites. Metabolism is the process to maintain living state of cell. Metabolism can be either anabolism or catabolism. Anabolism is the process in which certain compounds are synthesized that is required for cells to process, while breakdown of molecules for releasing energy is the catabolism. Metabolome is total set of metabolites present in a single organism. Metabolomics is study of chemical reactions related to metabolites and a field of analytical biochemistry. Metabolomics is used to compute and recognize the metabolites present in the cell via analytical technologies together with multi variant and statistical method for data interpretation.
Increasing scope of toxicological studies, clinical trials, rise in awareness for health and government and institution funds for research is expected to drive the demand for the metabolomics market. Lack of adoption of metabolomics technology and complexity of the process can hamper the metabolomics market. Increasing research and development expenditure and existing demand from emerging economies and is likely to open new market avenues in the near future.
Browse detail report with in-depth TOC @ http://bit.ly/2djxzea
The metabolomics market is segmented on the basis of technology, indication, application and region. Mass spectrometry, capillary electrophoresis, high performance liquid chromatography, gas chromatography and nuclear magnetic resonance spectroscopy are some of the major segments based on technology. High performance liquid chromatography was largest technology segment for metabolomics market. Drug discovery, biomarker and nutrigenomics are some of the key application markets for metabolomics. Drug discovery emerged as dominating segment due to its significant role in optimization, prioritization and drug target validation and identification for research. Cardiology and oncology are the indication for metabolomics.
The study provides a decisive view on the metabolomics market is segmented on basis of technology, indication, application and region. High performance liquid chromatography, mass spectrometry, capillary electrophoresis, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market. Applications include drug discovery, biomarker and nutrigenomics. Cardiology and oncology are the indication for metabolomics. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.
The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.
Read Report TOC http://bit.ly/2d9wx6u
This report segments for metabolomics market as follows:
Metabolomics Market: Technology Segment Analysis
High performance liquid chromatography
Nuclear magnetic resonance spectroscopy
Metabolomics Market: Indication Segment Analysis
Metabolomics Market: Application Segment Analysis
Metabolomics Market: Regional Segment Analysis
Middle East and Africa
About A to Z Research
A to Z Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. A to Z Research is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.
3422 SW 15 Street, Suite #8138,
Deerfield Beach, Florida 33442, USA
Tel: 386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No. 855-465-465